Bao Lab Selected Publications

See all of Dr. Ting Bao's publications on PubMed

1. Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium, (CCC19) Cohort Study
Nagaraj G, Vinayak S, Khaki AR, Sun T, Kuderer NM, Aboulafia DM, Acoba JD, Awosika J, Bakouny Z, Balmaceda NB, Bao T, Bashir B, Berg S, Bilen MA, Bindal P, Blau S, Bodin BE, Borno HT, Castellano C, Choi H, Deeken J, Desai A, Edwin N, Feldman LE, Flora DB, Friese CR, Galsky MD, Gonzalez CJ, Grivas P, Gupta S, Haynam M, Heilman H, Hershman DL, Hwang C, Jani C, Jhawar SR, Joshi M, Kaklamani V, Klein EJ, Knox N, Koshkin VS, Kulkarni AA, Kwon DH, Labaki C, Lammers PE, Lathrop KI, Lewis MA, Li X, de Lima Lopes G, Lyman GH, Makower DF, Mansoor AH, Markham MJ, Mashru SH, McKay RR, Messing I, Mico V, Nadkarni R, Namburi S, Nguyen RH, Nonato TK, O'Connor TL, Panagiotou OA, Park K, Patel JM, Patel KG, Peppercorn J, Polimera H, Puc M, Rao YJ, Razavi P, Reid SA, Riess JW, Rivera DR, Robson M, Rose SJ, Russ AD, Schapira L, Shah PK, Shanahan MK, Shapiro LC, Smits M, Stover DG, Streckfuss M, Tachiki L, Thompson MA, Tolaney SM, Weissmann LB, Wilson G, Wotman MT, Wulff-Burchfield EM, Mishra S, French B, Warner JL, Lustberg MB, Accordino MK, Shah DP. Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. medRxiv [Preprint]. 2023 Mar 10:2023.03.09.23287038. doi: 10.1101/2023.03.09.23287038. Update in: Elife. 2023 Oct 17;12: PMID: 37205429; PMCID: PMC10187350.

2. A randomized controlled trial testing a virtual program for Asian American women breast cancer survivors
Im EO, Chee W, Paul S, Choi MY, Kim SY, Deatrick JA, Inouye J, Ma G, Meghani S, Nguyen GT, Schapira MM, Ulrich CM, Yeo S, Bao T, Shin D, Mao JJ. A randomized controlled trial testing a virtual program for Asian American women breast cancer survivors. Nat Commun. 2023 Oct 14;14(1):6475. doi: 10.1038/s41467-023-42132-6. PMID: 37838727; PMCID: PMC10576740.

3. Interest in and Barriers to Practicing Yoga among Family Caregivers of People with Cancer
Desai K, Applebaum AJ, Latte-Naor S, Pendleton EM, Cheyney S, Li QS, Bao T, Chimonas S, Mao JJ. Interest in and Barriers to Practicing Yoga among Family Caregivers of People with Cancer. Int J Yoga. 2023 Jan-Apr;16(1):5-11. doi: 10.4103/ijoy.ijoy_203_22. Epub 2023 Jul 10. PMID: 37583540; PMCID: PMC10424271.

4. Patient Characteristics Associated with Chemotherapy-Induced Peripheral Neuropathy Severity in a Phase II Clinical Trial: A Retrospective Analysis
Zhi WI, Dreyfus N, Lessing A, Galantino M, Piulson L, Kot KL, Li S, Bao T. Patient Characteristics Associated With Chemotherapy-Induced Peripheral Neuropathy Severity in a Phase II Clinical Trial: A Retrospective Analysis. Oncologist. 2023 Jul 5;28(7):604-608. doi: 10.1093/oncolo/oyad062. PMID: 36972359; PMCID: PMC10322124.

5. Addressing cancer-related fatigue through sleep: A secondary analysis of a randomized trial comparing acupuncture and cognitive behavioral therapy for insomnia
Li X, Liou KT, Chimonas S, Bryl K, Wong G, Spiguel E, Li SQ, Garland SN, Bao T, Mao JJ. Addressing cancer-related fatigue through sleep: A secondary analysis of a randomized trial comparing acupuncture and cognitive behavioral therapy for insomnia. Integr Med Res. 2023 Mar;12(1):100922. doi: 10.1016/j.imr.2023.100922. Epub 2023 Feb 3. PMID: 36843902; PMCID: PMC9944506.

6. Tibetan Herbal Pain-Relieving Plaster for Chronic Musculoskeletal Pain Among Cancer Survivors: Study Protocol of a Randomized, Double-Blind, Placebo Controlled Trial
Yang M, Baser RE, Li SQ, Hou YN, Chong K, Zhang YL, Hoque I, Bao T, Mao JJ. Tibetan Herbal Pain-Relieving Plaster for Chronic Musculoskeletal Pain Among Cancer Survivors: Study Protocol of a Randomized, Double-Blind, Placebo-Controlled Trial. Front Pharmacol. 2022 May 4;13:878371. doi: 10.3389/fphar.2022.878371. PMID: 35600872; PMCID: PMC9114465.

7. Effects of Vigorous Versus Restorative Yoga Practice on Objective Functions in Sedentary Breast and Ovarian Cancer Survivors: A Randomized Controlled Pilot Trial
Deng G, Bao T, Ryan EL, Benusis L, Hogan P, Li QS, Dries A, Konner J, Ahles TA, Mao JJ. Effects of Vigorous Versus Restorative Yoga Practice on Objective Cognition Functions in Sedentary Breast and Ovarian Cancer Survivors: A Randomized Controlled Pilot Trial. Integr Cancer Ther. 2022 Jan-Dec;21:15347354221089221. doi: 10.1177/15347354221089221. PMID: 35861215; PMCID: PMC9403449.

8. Acupuncture versus cognitive behavioral therapy for pain among cancer survivors with insomnia: an exploratory analysis of a randomized clinical trial
Yang M, Liou KT, Garland SN, Bao T, Hung TKW, Li SQ, Li Y, Mao JJ. Acupuncture versus cognitive behavioral therapy for pain among cancer survivors with insomnia: an exploratory analysis of a randomized clinical trial. NPJ Breast Cancer. 2021 Nov 30;7(1):148. doi: 10.1038/s41523-021-00355-0. PMID: 34848737; PMCID: PMC8633385.

9. Health-Related Quality of Life in Cancer Survivors with Chemotherapy-Induced Neuropathy: A Randomized Clinical Trial
Bao T, Baser R, Chen C, Weitzman M, Zhang YL, Seluzicki C, Li QS, Piulson L, Zhi WI. Health-Related Quality of Life in Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Clinical Trial. Oncologist. 2021 Nov;26(11):e2070-e2078. doi: 10.1002/onco.13933. Epub 2021 Aug 26. PMID: 34390283; PMCID: PMC8571772.

10. Payer Coverage of Integrative Medicine Interventions for Symptoms Control in Patients with Cancer
Sedhom R, Gupta A, Wang L, Paller C, Bao T. Payer Coverage of Integrative Medicine Interventions for Symptom Control in Patients With Cancer. JCO Oncol Pract. 2021 Oct;17(10):587-590. doi: 10.1200/OP.21.00361. Epub 2021 Jul 26. PMID: 34310190.

11. Use of patient-reported controls for secular trends to study disparities in cancer-related job loss
Blinder VS, Eberle CE, Tran C, Bao T, Malik M, Jung G, Hwang C, Kampel L, Patil S, Gany FM. Use of patient-reported controls for secular trends to study disparities in cancer-related job loss. J Cancer Surviv. 2021 Oct;15(5):685-695. doi: 10.1007/s11764-020-00960-1. Epub 2020 Oct 26. PMID: 33106995; PMCID: PMC8071836.

12. Understanding interest, barriers, and preferences related to yoga practice among cancer survivors
Desai K, Bao T, Li QS, Raghunathan NJ, Trevino K, Green A, Xiao H, Mao JJ. Understanding interest, barriers, and preferences related to yoga practice among cancer survivors. Support Care Cancer. 2021 Sep;29(9):5313-5321. doi: 10.1007/s00520-021-06083-2. Epub 2021 Mar 4. PMID: 33660077; PMCID: PMC9364436.

13. Yoga for cancer survivors with chemotherapy-induced peripheral neuropathy: Health-related quality of life outcomes
Zhi WI, Baser RE, Zhi LM, Talukder D, Li QS, Paul T, Patterson C, Piulson L, Seluzicki C, Galantino ML, Bao T. Yoga for cancer survivors with chemotherapy-induced peripheral neuropathy: Health-related quality of life outcomes. Cancer Med. 2021 Aug;10(16):5456-5465. doi: 10.1002/cam4.4098. Epub 2021 Jul 2. PMID: 34213086; PMCID: PMC8366077.

14. Tibetan herbal pain-relieving plaster for lower back pain: A systematic review and meta-analysis
Yang M, Li SQ, Smith CM, Zhang YL, Bao T, Mao JJ. Tibetan herbal pain-relieving plaster for low back pain: A systematic review and meta-analysis. Biomed Pharmacother. 2021 Aug;140:111727. doi: 10.1016/j.biopha.2021.111727. Epub 2021 May 18. PMID: 34015584; PMCID: PMC9254726.

15. Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors: The PEACE Randomized Clinical Trial
Mao JJ, Liou KT, Baser RE, Bao T, Panageas KS, Romero SAD, Li QS, Gallagher RM, Kantoff PW. Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors: The PEACE Randomized Clinical Trial. JAMA Oncol. 2021 May 1;7(5):720-727. doi: 10.1001/jamaoncol.2021.0310. PMID: 33734288; PMCID: PMC7974834.

16. Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing
Zhi WI, Baser RE, Kwon A, Chen C, Li SQ, Piulson L, Seluzicki C, Panageas KS, Harte SE, Mao JJ, Bao T. Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing. Breast Cancer Res Treat. 2021 Apr;186(3):761-768. doi: 10.1007/s10549-020-06079-2. Epub 2021 Jan 28. PMID: 33507480; PMCID: PMC8406379.

17. Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled Trial
Bao T, Zhi I, Baser R, Hooper M, Chen C, Piulson L, Li QS, Galantino ML, Blinder V, Robson M, Seidman A, Panageas KS, Mao JJ. Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled Trial. JNCI Cancer Spectr. 2020 Jun 4;4(6):pkaa048. doi: 10.1093/jncics/pkaa048. PMID: 33225208; PMCID: PMC7666827.

18. Effect of Acupuncture vs Sham Procedure on Chemotherapy-Induced Peripheral neuropathy Symptoms: A Randomized Clinical Trial
Bao T, Patil S, Chen C, Zhi IW, Li QS, Piulson L, Mao JJ. Effect of Acupuncture vs Sham Procedure on Chemotherapy-Induced Peripheral Neuropathy Symptoms: A Randomized Clinical Trial. JAMA Netw Open. 2020 Mar 2;3(3):e200681. doi: 10.1001/jamanetworkopen.2020.0681. PMID: 32159808; PMCID: PMC7066475.

19. Both Race and Insurance Type Independently Predict the Selection of Oral Opioids Prescribed to Cancer Outpatients
Meghani SH, Rosa WE, Chittams J, Vallerand AH, Bao T, Mao JJ. Both Race and Insurance Type Independently Predict the Selection of Oral Opioids Prescribed to Cancer Outpatients. Pain Manag Nurs. 2020 Feb;21(1):65-71. doi: 10.1016/j.pmn.2019.07.004. Epub 2019 Sep 6. PMID: 31501079; PMCID: PMC6980435.

20. A Systematic Review of CheeZheng Pain Relieving Plaster for Musculoskeletal Pain: Implications for Oncology Research and Practice
Chen C, Li SQ, Bao T, Zhang L, Seluzicki C, Mao JJ. A Systematic Review of CheeZheng Pain Relieving Plaster for Musculoskeletal Pain: Implications for Oncology Research and Practice. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420918933. doi: 10.1177/1534735420918933. PMID: 32880472; PMCID: PMC7485161.

21. Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing
Zhi WI, Chen P, Kwon A, Chen C, Harte SE, Piulson L, Li S, Patil S, Mao JJ, Bao T. Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing. Breast Cancer Res Treat. 2019 Dec;178(3):587-595. doi: 10.1007/s10549-019-05416-4. Epub 2019 Aug 27. PMID: 31456070; PMCID: PMC6819268.

22. Acupuncture Versus Cognitive Behavioral Therapy for Insomnia in Cancer Survivors: A Randomized Clinical Trial
Garland SN, Xie SX, DuHamel K, Bao T, Li Q, Barg FK, Song S, Kantoff P, Gehrman P, Mao JJ. Acupuncture Versus Cognitive Behavioral Therapy for Insomnia in Cancer Survivors: A Randomized Clinical Trial. J Natl Cancer Inst. 2019 Dec 1;111(12):1323-1331. doi: 10.1093/jnci/djz050. PMID: 31081899; PMCID: PMC6910189.

23. A Technology-Assisted, Brief Mind-Body Intervention to Improve the Waiting Room Experience for Chemotherapy Patients: Randomized Quality Improvement Study
Bao T, Deng G, DeMarzo LA, Zhi WI, DeRito JL, Blinder V, Chen C, Li QS, Green J, Pendleton E, Mao JJ. A Technology-Assisted, Brief Mind-Body Intervention to Improve the Waiting Room Experience for Chemotherapy Patients: Randomized Quality Improvement Study. JMIR Cancer. 2019 Nov 7;5(2):e13217. doi: 10.2196/13217. PMID: 31697238; PMCID: PMC6873148.

24. The Relationship Between Insomnia and Cognitive Impairment in Breast Cancer Survivors
Liou KT, Ahles TA, Garland SN, Li QS, Bao T, Li Y, Root JC, Mao JJ. The Relationship Between Insomnia and Cognitive Impairment in Breast Cancer Survivors. JNCI Cancer Spectr. 2019 Jun 7;3(3):pkz041. doi: 10.1093/jncics/pkz041. PMID: 31355357; PMCID: PMC6640530.

25. Joint pain and falls among women with breast cancer on aromatase inhibitors
Basal C, Vertosick E, Gillis TA, Li Q, Bao T, Vickers A, Mao JJ. Joint pain and falls among women with breast cancer on aromatase inhibitors. Support Care Cancer. 2019 Jun;27(6):2195-2202. doi: 10.1007/s00520-018-4495-4. Epub 2018 Oct 10. PMID: 30306326; PMCID: PMC6758909.

26. Challenges in a Technology-Based Cancer Pain Management Program Among Asian American Breast Cancer Survivors
Im EO, Ji X, Kim S, Chee E, Bao T, Mao JJ, Chee W. Challenges in a Technology-Based Cancer Pain Management Program Among Asian American Breast Cancer Survivors. Comput Inform Nurs. 2019 May;37(5):243-249. doi: 10.1097/CIN.0000000000000503. PMID: 31094913; PMCID: PMC6530489.

27. Acupuncture for Bortezomib-Induced Peripheral Neuropathy: Not Just for Pain
Zhi WI, Ingram E, Li SQ, Chen P, Piulson L, Bao T. Acupuncture for Bortezomib-Induced Peripheral Neuropathy: Not Just for Pain. Integr Cancer Ther. 2018 Dec;17(4):1079-1086. doi: 10.1177/1534735418788667. Epub 2018 Jul 20. PMID: 30027756; PMCID: PMC6247555.

28. A phase IIA trial of acupuncture to reduce chemotherapy induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients
Bao T, Seidman AD, Piulson L, Vertosick E, Chen X, Vickers AJ, Blinder VS, Zhi WI, Li Q, Vahdat LT, Dickler MN, Robson ME, Mao JJ. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients. Eur J Cancer. 2018 Sep;101:12-19. doi: 10.1016/j.ejca.2018.06.008. Epub 2018 Jul 13. PMID: 30007894; PMCID: PMC6147260.

29. Barriers to Acupuncture Use Among Breast Cancer Survivors: A Cross-Sectional Analysis
Bao T, Li Q, DeRito JL, Seluzicki C, Im EO, Mao J. Barriers to Acupuncture Use Among Breast Cancer Survivors: A Cross-Sectional Analysis. Integr Cancer Ther. 2018 Sep;17(3):854-859. doi: 10.1177/1534735418754309. Epub 2018 Jan 17. PMID: 29338443; PMCID: PMC6142082.

30. Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors
Mao H, Bao T, Shen X, Li Q, Seluzicki C, Im EO, Mao JJ. Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors. Eur J Cancer. 2018 Sep;101:47-54. doi: 10.1016/j.ejca.2018.06.009. Epub 2018 Jul 14. PMID: 30014974; PMCID: PMC6148367.

31. Acupuncture for breast cancer-related lymphedema: a randomized controlled trial
Bao T, Iris Zhi W, Vertosick EA, Li QS, DeRito J, Vickers A, Cassileth BR, Mao JJ, Van Zee KJ. Acupuncture for breast cancer-related lymphedema: a randomized controlled trial. Breast Cancer Res Treat. 2018 Jul;170(1):77-87. doi: 10.1007/s10549-018-4743-9. Epub 2018 Mar 8. PMID: 29520533; PMCID: PMC6159216.

32. Living with chronic pain: perceptions of breast cancer survivors
Bao T, Seidman A, Li Q, Seluzicki C, Blinder V, Meghani SH, Farrar JT, Mao JJ. Living with chronic pain: perceptions of breast cancer survivors. Breast Cancer Res Treat. 2018 May;169(1):133-140. doi: 10.1007/s10549-018-4670-9. Epub 2018 Jan 19. PMID: 29350307; PMCID: PMC6147242.

33. Acupuncture versus medication for pain management: a cross-sectional study of breast cancer survivors
Bao T, Li SQ, Dearing JL, Piulson LA, Seluzicki CM, Sidlow R, Mao JJ. Acupuncture versus medication for pain management: a cross-sectional study of breast cancer survivors. Acupunct Med. 2018 Apr;36(2):80-87. doi: 10.1136/acupmed-2017-011435. Epub 2018 Feb 10. PMID: 29440043; PMCID: PMC6264909.

34. The National Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps
Zia FZ, Olaku O, Bao T, Berger A, Deng G, Fan AY, Garcia MK, Herman PM, Kaptchuk TJ, Ladas EJ, Langevin HM, Lao L, Lu W, Napadow V, Niemtzow RC, Vickers AJ, Shelley Wang X, Witt CM, Mao JJ. The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps. J Natl Cancer Inst Monogr. 2017 Nov 1;2017(52):lgx005. doi: 10.1093/jncimonographs/lgx005. PMID: 29140486; PMCID: PMC6061411.

35. State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshops Highlights of Discussion Report
Xi D, Bao T, Chen Q, Chen S, Cheng YC, Cullen J, Frank DA, Friedberg JW, Kronish I, Lee JE, Levine M, Li P, Li S, Lu W, Mao JJ, O'Keefe S, Rubinstein L, Shah MA, Standish L, Paller CJ, Chu E. State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion Report. J Natl Cancer Inst Monogr. 2017 Nov 1;2017(52):lgx003. doi: 10.1093/jncimonographs/lgx003. PMID: 29140484; PMCID: PMC6061228.

36. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk
Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat. 2016 Sep;159(2):327-33. doi: 10.1007/s10549-016-3939-0. Epub 2016 Aug 10. PMID: 27510185; PMCID: PMC5509538.

37. Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review
Brami C, Bao T, Deng G. Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review. Crit Rev Oncol Hematol. 2016 Feb;98:325-34. doi: 10.1016/j.critrevonc.2015.11.014. Epub 2015 Nov 23. PMID: 26652982; PMCID: PMC4727999.

38. Manual lymphatic drainage for lymphedema following breast cancer treatment
Ezzo J, Manheimer E, McNeely ML, Howell DM, Weiss R, Johansson KI, Bao T, Bily L, Tuppo CM, Williams AF, Karadibak D. Manual lymphatic drainage for lymphedema following breast cancer treatment. Cochrane Database Syst Rev. 2015 May 21;2015(5):CD003475. doi: 10.1002/14651858.CD003475.pub2. PMID: 25994425; PMCID: PMC4966288.

39. A pilot study for acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma
Bao T, Goloubeva O, Pelser C, Porter N, Primrose J, Hester L, Sadowska M, Lapidus R, Medeiros M, Lao L, Dorsey SG, Badros AZ. A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma. Integr Cancer Ther. 2014 Sep;13(5):396-404. doi: 10.1177/1534735414534729. Epub 2014 May 26. PMID: 24867959; PMCID: PMC4562796.

40. Chemotherapy dose reduction due to chemotherapy-induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience
Bhatnagar B, Gilmore S, Goloubeva O, Pelser C, Medeiros M, Chumsri S, Tkaczuk K, Edelman M, Bao T. Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience. Springerplus. 2014 Jul 16;3:366. doi: 10.1186/2193-1801-3-366. PMID: 25089251; PMCID: PMC4117856.

41. Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms
Bao T, Cai L, Snyder C, Betts K, Tarpinian K, Gould J, Jeter S, Medeiros M, Chumsri S, Bardia A, Tan M, Singh H, Tkaczuk KH, Stearns V. Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms. Cancer. 2014 Feb 1;120(3):381-9. doi: 10.1002/cncr.28352. Epub 2013 Dec 23. PMID: 24375332; PMCID: PMC3946917.

42. A dual-center randomized controlled double blind trail assessing the effect of acupuncture ibn reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors
Bao T, Cai L, Giles JT, Gould J, Tarpinian K, Betts K, Medeiros M, Jeter S, Tait N, Chumsri S, Armstrong DK, Tan M, Folkerd E, Dowsett M, Singh H, Tkaczuk K, Stearns V. A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors. Breast Cancer Res Treat. 2013 Feb;138(1):167-74. doi: 10.1007/s10549-013-2427-z. Epub 2013 Feb 8. PMID: 23393007; PMCID: PMC3594526.

43. Aromatase, aromatase inhibitors, and breast cancer
Chumsri S, Howes T, Bao T, Sabnis G, Brodie A. Aromatase, aromatase inhibitors, and breast cancer. J Steroid Biochem Mol Biol. 2011 May;125(1-2):13-22. doi: 10.1016/j.jsbmb.2011.02.001. Epub 2011 Feb 16. PMID: 21335088; PMCID: PMC3104073.

44. Severe prolonged cholestatic hepatitis caused by exemestane
Bao T, Fetting J, Mumford L, Zorzi J, Shahverdi K, Jeter S, Herlong F, Stearns V, Lee L. Severe prolonged cholestatic hepatitis caused by exemestane. Breast Cancer Res Treat. 2010 Jun;121(3):789-91. doi: 10.1007/s10549-009-0576-x. Epub 2009 Oct 16. PMID: 19834799; PMCID: PMC3085997.

45. Gene expression profiling of breast cancer
Bao T, Davidson NE. Gene expression profiling of breast cancer. Adv Surg. 2008;42:249-60. doi: 10.1016/j.yasu.2008.03.002. PMID: 18953822; PMCID: PMC2775529.